Group One Trading’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Group One Trading’s Portfolio CALT Stock Details CALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,000	Closed	-$51.5K	–	8157
2023 Q4	$51.5K	Buy	+2,000	New	+$37.5K	﹤0.01%	5034
2023 Q2	–	Sell	-200	Closed	-$4.79K	–	8331
2023 Q1	$4.79K	Buy	+200	New	+$4K	﹤0.01%	6293
2022 Q2	–	Sell	-100	Closed	-$2K	–	8706
2022 Q1	$2K	Sell	100 -800	-89%	-$16K	﹤0.01%	7767
2021 Q4	$22K	Buy	+900	New	+$18.1K	﹤0.01%	6931

Other funds holding CALT

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

IIM

Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Group One Trading's CALT Position: Q2 2023 in Review

Group One Trading sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q2 2023, closing a stake of 705 shares — an estimated $16.9K sold.

Group One Trading first reported a position in CALT in Q1 2023 and held it in 1 quarter. The position peaked at $16.9K in Q1 2023. 16 funds tracked by Wall St. Rank hold CALT as of Q2 2023.

Group One Trading reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Group One Trading sold 705 Calliditas Therapeutics AB American Depositary Shares shares in Q2 2023, an estimated $16.9K.
Group One Trading first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q1 2023 and held it in 1 quarter.
Group One Trading's Calliditas Therapeutics AB American Depositary Shares position peaked at $16.9K in Q1 2023.
16 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.